570 related articles for article (PubMed ID: 26847061)
21. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M
Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445
[TBL] [Abstract][Full Text] [Related]
22. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
[TBL] [Abstract][Full Text] [Related]
23. "Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".
Tarrad NAF; Hassan S; Shaker OG; AbdelKawy M
BMC Oral Health; 2023 Dec; 23(1):994. PubMed ID: 38087258
[TBL] [Abstract][Full Text] [Related]
24. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
25. Prevalidation of salivary biomarkers for oral cancer detection.
Elashoff D; Zhou H; Reiss J; Wang J; Xiao H; Henson B; Hu S; Arellano M; Sinha U; Le A; Messadi D; Wang M; Nabili V; Lingen M; Morris D; Randolph T; Feng Z; Akin D; Kastratovic DA; Chia D; Abemayor E; Wong DT
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):664-72. PubMed ID: 22301830
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
27. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
28. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
[TBL] [Abstract][Full Text] [Related]
29. Risk Stratification System for Oral Cancer Screening.
Pereira LH; Reis IM; Reategui EP; Gordon C; Saint-Victor S; Duncan R; Gomez C; Bayers S; Fisher P; Perez A; Goodwin WJ; Hu JJ; Franzmann EJ
Cancer Prev Res (Phila); 2016 Jun; 9(6):445-55. PubMed ID: 27020654
[TBL] [Abstract][Full Text] [Related]
30. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
[TBL] [Abstract][Full Text] [Related]
31. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
32. Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection.
Pereira LH; Adebisi IN; Perez A; Wiebel M; Reis I; Duncan R; Goodwin WJ; Hu JJ; Lokeshwar VB; Franzmann EJ
Cancer Biomark; 2011; 10(5):241-9. PubMed ID: 22699785
[TBL] [Abstract][Full Text] [Related]
33. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity.
Rajkumar K; Nandhini G; Ramya R; Rajashree P; Kumar AR; Anandan SN
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):309-19. PubMed ID: 24950604
[TBL] [Abstract][Full Text] [Related]
34. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
35. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
36. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.
Hsu CW; Yu JS; Peng PH; Liu SC; Chang YS; Chang KP; Wu CC
J Proteome Res; 2014 Nov; 13(11):4796-807. PubMed ID: 24708169
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Accuracy of Salivary Biomarkers in Detecting Early Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shaw AK; Garcha V; Shetty V; Vinay V; Bhor K; Ambildhok K; Karande P
Asian Pac J Cancer Prev; 2022 May; 23(5):1483-1495. PubMed ID: 35633529
[TBL] [Abstract][Full Text] [Related]
38. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
39. Salivary Interleukin Levels in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: Findings from a Sri Lankan Study.
Piyarathne NS; Weerasekera MM; Fonseka PFD; Karunatilleke AHTS; Liyanage RLPR; Jayasinghe RD; De Silva K; Yasawardene S; Gupta E; Jayasinghe JAP; Abu-Eid R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900301
[TBL] [Abstract][Full Text] [Related]
40. Salivary interleukin-6 and -8 in patients with oral cancer and patients with chronic oral inflammatory diseases.
Lisa Cheng YS; Jordan L; Gorugantula LM; Schneiderman E; Chen HS; Rees T
J Periodontol; 2014 Jul; 85(7):956-65. PubMed ID: 24147842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
